Krebs Biochemicals and Industries per share figures

·Pharma & HealthChart ›
MultiplesEnterprise valuePer share
Share price at each year-end
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
−₹6.19−₹7.85−₹12.49−₹9.16−₹11.30
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
−₹6.19−₹7.85−₹12.49−₹9.16−₹11.30
−₹75.49−₹75.49−₹67.83−₹55.29−₹46.13
₹12.46₹11.01₹20.09₹23.39₹24.18
—−₹0.89−₹3.66₹1.07−₹12.29
−₹2.75−₹2.75−₹6.04−₹2.56−₹17.33
2.22.22.22.22.2
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

KREBSBIO₹59.15

Krebs Biochemicals and Industries Limited

· Pharma & Health
₹ CrorePeersALPABALPHARMAVINEETLABNATCAPSUQBIOFILCHEMNECLIFEMANGALAMAAREYDRUGSMcap ₹128 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
₹ per share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Basic EPS-11.30-9.16-12.49-7.85-6.19
Diluted EPS-11.30-9.16-12.49-7.85-6.19
Book Value per Share-46.13-55.29-67.83-75.49-75.49
Revenue per Share24.1823.3920.0911.0112.46
Cash Flow per Share-12.291.07-3.66-0.89—
Free Cash Flow per Share-17.33-2.56-6.04-2.75-2.75
Shares Outstanding (cr)2.22.22.22.22.2
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.